Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT) is a prominent Austrian research institution specializing in cardiovascular disease, diabetes, and metabolic disorders. Established in 1997, the institute focuses on molecular biology, genetic epidemiology, and clinical research to improve patient care through personalized medicine. VIVIT operates a comprehensive biobank and maintains a significant database used for long-term clinical studies on biomarkers and therapeutic outcomes. The institute collaborates with international pharmaceutical companies to conduct clinical trials and validate new diagnostic tools. Their research spans from basic laboratory science to large-scale longitudinal clinical investigations in the Alpine region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vorarlberg Institute for Vascular Investigation and Treatment.